US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Navigating a 19% Potential Upside with Strategic Insights

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector’s diagnostics and research industry, continues to be a focal point for investors seeking opportunities within analytical..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the 80.69% Potential Upside Amidst Challenges

Moderna, Inc. (NASDAQ: MRNA) has been a focal point in the biotechnology sector, especially following its pivotal role in developing COVID-19 vaccines. As investors look towards..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring Growth Potential Amid Healthcare Sector Dynamics

Bausch + Lomb Corporation (NYSE: BLCO) stands out in the healthcare sector, specifically within the medical instruments and supplies industry. Based in Vaughan, Canada, this renowned..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 29% Potential Upside with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, continues to capture investor interest with its innovative approach in the medical instruments..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Eyeing an 18.97% Upside with Robust Revenue Growth

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is gaining significant traction among investors...

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 32.59% Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a key player in the healthcare information services sector, is attracting significant attention in the investment community. With a market capitalization..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 24% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is gaining attention with its promising 24.08% potential upside, according to analysts. With a focus..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 24.28% Potential Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector with a robust focus on neurological and neurodegenerative diseases, presents an intriguing investment opportunity with a..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a Healthcare Giant with a Compelling 8.41% Upside

Universal Health Services, Inc. (NYSE: UHS), a formidable player in the healthcare sector, operates a network of acute care hospitals and behavioral health facilities across the..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Partnerships

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, continues to capture investor interest with its innovative drug delivery platforms and robust growth..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 30.9% Revenue Growth in the Precision Oncology Space

Guardant Health, Inc. (NASDAQ: GH), a pioneering leader in the precision oncology sector, is capturing the attention of investors with its robust 30.9% revenue growth, despite..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 42.65% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a leading player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing proposition for investors keen on the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention

In the dynamic world of biotechnology, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out as a notable player with potential for substantial growth. Headquartered in Dublin, Ireland,..

Verona Pharma plc (VRNA) Stock Analysis: Evaluating Growth Potential Amidst a $9.07 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical company, has been garnering attention in the healthcare sector, particularly within the biotechnology industry. Specializing in the development..

Globus Medical, Inc. (GMED) Stock Analysis: Discovering a 44% Potential Upside

For investors keen on healthcare opportunities, Globus Medical, Inc. (NYSE: GMED) presents an intriguing prospect within the medical devices sector. Headquartered in Audubon, Pennsylvania, the company..

Option Care Health, Inc. (OPCH) Stock Analysis: Poised for a 42% Upside with Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector specializing in home and alternate site infusion services, is drawing significant attention from..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Compelling 78% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity with a strong potential upside. With a..

Glaukos Corporation (GKOS) Stock Analysis: Navigating the 52.65% Potential Upside in the Healthcare Sector

Glaukos Corporation (GKOS), a key player in the healthcare sector, stands out in the niche field of ophthalmic pharmaceuticals and medical technology. With a focus on..

Chemed Corp (CHE) Stock Analysis: Unpacking the 25% Potential Upside in Healthcare

For investors seeking an intriguing opportunity in the healthcare sector, Chemed Corp (NYSE: CHE) presents a compelling case. With a market capitalization of $6.74 billion, Chemed..

Legend Biotech (LEGN) Stock Analysis: Unlocking a 129.77% Potential Upside in the Biotech Arena

Legend Biotech Corporation (NASDAQ: LEGN), a trailblazer in the biopharmaceutical realm, is capturing investor attention with a significant 129.77% potential upside. As a leader in developing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds